Trial intelligence / Profile preview

Tranilast in COVID-19

IRCT20200419047128N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranilast in coronavirus disease 2019 (COVID-19), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started May 2020; status: completed.

02

Drugs

tranilast
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on IRCT20200419047128N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200419047128N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call